Emerging medical therapies for severe alcoholic hepatitis
Severe alcoholic hepatitis (AH) is an acute and often devastating form of alcohol-associated liver disease. Clinically, AH is characterized by elevated bilirubin, model for end stage liver disease scores >20, and nonspecific symptoms that are caused by underlying inflammation, hepatocyte injury,...
Main Authors: | David Tornai, Gyongyi Szabo |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Association for the Study of the Liver
2020-10-01
|
Series: | Clinical and Molecular Hepatology |
Subjects: | |
Online Access: | http://e-cmh.org/upload/pdf/cmh-2020-0145.pdf |
Similar Items
-
Intercellular Communication between Hepatic Cells in Liver Diseases
by: Keisaku Sato, et al.
Published: (2019-05-01) -
The role of the gut microbiome and diet in the pathogenesis of non-alcoholic fatty liver disease
by: Erica Jennison, et al.
Published: (2021-01-01) -
Double Knockdown of PHD1 and Keap1 Attenuated Hypoxia-Induced Injuries in Hepatocytes
by: Jing Liu, et al.
Published: (2017-05-01) -
Effects of Simultaneous Downregulation of PHD1 and Keap1 on Prevention and Reversal of Liver Fibrosis in Mice
by: Jing Liu, et al.
Published: (2018-05-01) -
Molecular Mechanisms and New Treatment Strategies for Non-Alcoholic Steatohepatitis (NASH)
by: Akinobu Takaki, et al.
Published: (2014-04-01)